SBIO Among Health Care ETFs
End-of-day Nov 20, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.0% | −8.4% | −6.6% | −25.8% | −0.5% | +9.4% | +109.5% | +14.0% | +119.7% | +122.8% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$50 of every $1,000 in SBIO is CG
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | CGONCG oncology | Healthcare | 5.04% | $503.98 | 108K | $8.9M |
| 2 | ORKAOruka Therapeutics | Healthcare | 4.49% | $448.80 | 81K | $7.9M |
| 3 | MANEVeraDermics | Healthcare | 3.61% | $361.38 | 51K | $6.4M |
| 4 | DNTHDianthus Therapeutics | Healthcare | 3.30% | $329.83 | 68K | $5.8M |
| 5 | TVTXTravere Therapeutics | Healthcare | 3.16% | $315.80 | 115K | $5.6M |
| 6 | EWTXEdgewise Therapeutics | Healthcare | 3.10% | $310.40 | 133K | $5.5M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.75% | $274.93 | 164K | $4.8M |
| 8 | XENEXenon Pharmaceuticals | Healthcare | 2.53% | $252.91 | 119K | $4.5M |
| 9 | VRDNViridian Therapeutics | Healthcare | 2.48% | $247.65 | 139K | $4.4M |
| 10 | RLAYRelay Therapeutics | Healthcare | 2.42% | $242.44 | 268K | $4.3M |
| 11 | TARSTarsus Pharmaceuticals | Healthcare | 2.37% | $236.97 | 54K | $4.2M |
| 12 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.29% | $228.70 | 154K | $4.0M |
| 13 | ACADACADIA Pharmaceuticals | Healthcare | 2.10% | $210.29 | 210K | $3.7M |
| 14 | SLSSELLAS Life Sciences Group | Healthcare | 2.09% | $208.67 | 247K | $3.7M |
| 15 | DYNDyne Therapeutics | Healthcare | 2.08% | $208.16 | 229K | $3.7M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | CGON | CG oncology | 5.04% |
| 2 | ORKA | Oruka Therapeutics | 4.49% |
| 3 | MANE | VeraDermics | 3.61% |
| 4 | DNTH | Dianthus Therapeutics | 3.30% |
| 5 | TVTX | Travere Therapeutics | 3.16% |
| 6 | EWTX | Edgewise Therapeutics | 3.10% |
| 7 | DFTX | Definium Therapeutics | 2.75% |
| 8 | XENE | Xenon Pharmaceuticals | 2.53% |
| 9 | VRDN | Viridian Therapeutics | 2.48% |
| 10 | RLAY | Relay Therapeutics | 2.42% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |